Intervention

Enfuvirtide

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 17 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials17

Recruiting0

Common conditions3

Lead sponsors shown8

Clinical trials

17 shown

Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 IndividualsNCT01836068 · 2013-06-01

Optimizing Treatment for Treatment-Experienced, HIV-Infected PeopleNCT00537394 · 2008-01-01

Study of Valproic Acid to Treat HIV Infected AdultsNCT00312546 · 2006-06-01

A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment ExperienceNCT00487188 · 2005-11-01

Metabolic Effects of Enfuvirtide in Healthy VolunteersNCT00657761 · 2005-09-01

Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)NCT00120367 · 2005-04-01

A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of TherapyNCT00344760 · 2005-01-01

Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) InfectionNCT02733419 · 2004-12-01

A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) InfectionNCT02582983 · 2004-02-01

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive AdultsNCT00051831 · 2003-10-01

T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and AdolescentsNCT00022763 · 2001-08-01

A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected AdultsNCT00002239 · 1999-05-01

Study of a New Anti-HIV Drug, T-20, in HIV-Infected ChildrenNCT00001118

Adding New Drugs for HIV Infected Patients Failing Current TherapyNCT00031044

T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV DrugsNCT00021554

T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV DrugsNCT00008528

A Study of T-20 in HIV-Positive AdultsNCT00002228

Common conditions

HIV Infections16 HIV1 Leukoencephalopathy, Progressive Multifocal1

Leading sponsors

Hoffmann-La Roche 7 National Institute of Allergy and Infectious Diseases (NIAID) 4 French National Agency for Research on AIDS and Viral Hepatitis 1 Hospital Clinic of Barcelona 1 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1 Trimeris 1 University of Maryland, Baltimore 1 University of North Carolina, Chapel Hill 1

Trial status mix

COMPLETED16

TERMINATED1

Phase mix

PHASE25

PHASE34

PHASE44

PHASE13

EARLY_PHASE11

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.